Precision BioSciences, Inc.
DTIL · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $65 | $46 | $4,432 | $26 |
| - Cash | $45 | $62 | $77 | $86 |
| + Debt | $1 | $29 | $30 | $30 |
| Enterprise Value | $22 | $14 | $4,385 | -$30 |
| Revenue | $0 | $0 | $0 | $1 |
| % Growth | -27.8% | -37.9% | -95.5% | – |
| Gross Profit | -$1 | -$1 | $0 | $1 |
| % Margin | -5,084.6% | -3,766.7% | 100% | 100% |
| EBITDA | -$21 | -$22 | -$20 | -$17 |
| % Margin | -159,507.7% | -124,811.1% | -67,262.1% | -2,601.3% |
| Net Income | -$22 | -$24 | -$21 | -$18 |
| % Margin | -167,476.9% | -130,666.7% | -70,913.8% | -2,781.3% |
| EPS Diluted | -1.842 | -2.13 | -2.29 | -2.5 |
| % Growth | 13.5% | 7% | 8.4% | – |
| Operating Cash Flow | -$15 | -$20 | -$19 | -$19 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$15 | -$20 | -$19 | -$19 |